Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (331-340 of 721) with videos related to

Pageof 73
Sort By:
Cancers|July 2, 2021
Evaluation of the Predictive Potential of 18F-FDG PET and DWI Data Sets for Relevant Prognostic Parameters of Primary Soft-Tissue SarcomasMichal Chodyla, Aydin Demircioglu, Benedikt M Schaarschmidt, et al.
International Journal of Molecular Sciences|April 13, 2023
One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-RadiotherapyThomas Hager, Sabrina Borchert, Michael Wessolly, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2017
Prostate-Specific Membrane Antigen Ligands for Imaging and TherapyMatthias Eiber, Wolfgang P Fendler, Steven P Rowe, et al.
Theranostics|October 3, 2025
Transcriptomic Profiling of the Tumor Immune Microenvironment Reveals Prognostic Markers in mCRPC Patients Treated with LuPSMA TherapyAnalena Handke, Leonor Lopes, Claudia Kesch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2014
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trialFrancesco Ceci, Ken Herrmann, Paolo Castellucci, et al.
Plos One|January 18, 2020
18F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitisCornelius Deuschl, Theodor Rüber, Leon Ernst, et al.
International Journal of Environmental Research and Public Health|March 3, 2021
Mental Health Burden of German Cancer Patients before and after the Outbreak of COVID-19: Predictors of Mental Health ImpairmentAlexander Bäuerle, Venja Musche, Kira Schmidt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2017
Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CTMatthias Eiber, Ken Herrmann, Jeremie Calais, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 3, 2013
Interim endoscopy results during neoadjuvant therapy for gastric cancer correlate with histopathological response and prognosisUlrike Heger, Franz Bader, Florian Lordick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 29, 2023
Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with <sup>223</sup>Ra: PARABO, a Prospective, Noninterventional StudyHolger Palmedo, Hojjat Ahmadzadehfar, Susanne Eschmann, et al.
Pageof 73

Showing results (331-340 of 721) with videos related to

Sort By:
Pageof 73
Cancers|July 2, 2021
Evaluation of the Predictive Potential of 18F-FDG PET and DWI Data Sets for Relevant Prognostic Parameters of Primary Soft-Tissue SarcomasMichal Chodyla, Aydin Demircioglu, Benedikt M Schaarschmidt, et al.
International Journal of Molecular Sciences|April 13, 2023
One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-RadiotherapyThomas Hager, Sabrina Borchert, Michael Wessolly, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2017
Prostate-Specific Membrane Antigen Ligands for Imaging and TherapyMatthias Eiber, Wolfgang P Fendler, Steven P Rowe, et al.
Theranostics|October 3, 2025
Transcriptomic Profiling of the Tumor Immune Microenvironment Reveals Prognostic Markers in mCRPC Patients Treated with LuPSMA TherapyAnalena Handke, Leonor Lopes, Claudia Kesch, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 4, 2014
Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trialFrancesco Ceci, Ken Herrmann, Paolo Castellucci, et al.
Plos One|January 18, 2020
18F-FDG-PET/MRI in the diagnostic work-up of limbic encephalitisCornelius Deuschl, Theodor Rüber, Leon Ernst, et al.
International Journal of Environmental Research and Public Health|March 3, 2021
Mental Health Burden of German Cancer Patients before and after the Outbreak of COVID-19: Predictors of Mental Health ImpairmentAlexander Bäuerle, Venja Musche, Kira Schmidt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 11, 2017
Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CTMatthias Eiber, Ken Herrmann, Jeremie Calais, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 3, 2013
Interim endoscopy results during neoadjuvant therapy for gastric cancer correlate with histopathological response and prognosisUlrike Heger, Franz Bader, Florian Lordick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 29, 2023
Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with <sup>223</sup>Ra: PARABO, a Prospective, Noninterventional StudyHolger Palmedo, Hojjat Ahmadzadehfar, Susanne Eschmann, et al.
Pageof 73